New anti-cancer 'degrader' targets protein essential to infant leukemia
byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Updated on: September 10,2024
0

New anti-cancer 'degrader' targets protein essential to infant leukemia
byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Updated on:September 10,2024
0
